Vbi Vaccines Stock Cash Per Share
VBI Vaccines fundamentals help investors to digest information that contributes to VBI Vaccines' financial success or failures. It also enables traders to predict the movement of VBI Stock. The fundamental analysis module provides a way to measure VBI Vaccines' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to VBI Vaccines stock.
VBI |
VBI Vaccines Company Cash Per Share Analysis
VBI Vaccines' Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
Current VBI Vaccines Cash Per Share | 0.32 X |
Most of VBI Vaccines' fundamental indicators, such as Cash Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, VBI Vaccines is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.
CompetitionIn accordance with the recently published financial statements, VBI Vaccines has a Cash Per Share of 0.32 times. This is 92.64% lower than that of the Biotechnology sector and 92.61% lower than that of the Health Care industry. The cash per share for all United States stocks is 93.61% higher than that of the company.
VBI Cash Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses VBI Vaccines' direct or indirect competition against its Cash Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of VBI Vaccines could also be used in its relative valuation, which is a method of valuing VBI Vaccines by comparing valuation metrics of similar companies.VBI Vaccines is currently under evaluation in cash per share category among its peers.
VBI Fundamentals
| Return On Equity | -4.2 | |||
| Return On Asset | -0.29 | |||
| Operating Margin | (9.68) % | |||
| Current Valuation | 38.92 M | |||
| Shares Outstanding | 28.68 M | |||
| Shares Owned By Insiders | 6.76 % | |||
| Shares Owned By Institutions | 13.00 % | |||
| Number Of Shares Shorted | 276.87 K | |||
| Price To Earning | (3.79) X | |||
| Price To Book | 1.24 X | |||
| Price To Sales | 0.20 X | |||
| Revenue | 8.68 M | |||
| Gross Profit | (10.19 M) | |||
| EBITDA | (53.32 M) | |||
| Net Income | (92.84 M) | |||
| Cash And Equivalents | 82.41 M | |||
| Cash Per Share | 0.32 X | |||
| Total Debt | 53.04 M | |||
| Debt To Equity | 0.32 % | |||
| Current Ratio | 2.29 X | |||
| Book Value Per Share | (0.22) X | |||
| Cash Flow From Operations | (60.88 M) | |||
| Short Ratio | 1.57 X | |||
| Earnings Per Share | (3.54) X | |||
| Target Price | 5.0 | |||
| Number Of Employees | 131 | |||
| Beta | 2.17 | |||
| Market Capitalization | 1.87 M | |||
| Total Asset | 86.95 M | |||
| Retained Earnings | (582.45 M) | |||
| Working Capital | (39.51 M) | |||
| Current Asset | 7.89 M | |||
| Current Liabilities | 3.03 M | |||
| Net Asset | 86.95 M |
About VBI Vaccines Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze VBI Vaccines's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of VBI Vaccines using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of VBI Vaccines based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Consideration for investing in VBI Stock
If you are still planning to invest in VBI Vaccines check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the VBI Vaccines' history and understand the potential risks before investing.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |